598 related articles for article (PubMed ID: 21258964)
1. AMP-activated protein kinase inhibits homocysteine-induced dysfunction and apoptosis in endothelial progenitor cells.
Jia F; Wu C; Chen Z; Lu G
Cardiovasc Drugs Ther; 2011 Feb; 25(1):21-9. PubMed ID: 21258964
[TBL] [Abstract][Full Text] [Related]
2. Atorvastatin inhibits homocysteine-induced oxidative stress and apoptosis in endothelial progenitor cells involving Nox4 and p38MAPK.
Bao XM; Wu CF; Lu GP
Atherosclerosis; 2010 May; 210(1):114-21. PubMed ID: 20018284
[TBL] [Abstract][Full Text] [Related]
3. Atorvastatin inhibits homocysteine-induced dysfunction and apoptosis in endothelial progenitor cells.
Bao XM; Wu CF; Lu GP
Acta Pharmacol Sin; 2010 Apr; 31(4):476-84. PubMed ID: 20305681
[TBL] [Abstract][Full Text] [Related]
4. Atorvastatin inhibits homocysteine-induced endoplasmic reticulum stress through activation of AMP-activated protein kinase.
Jia F; Wu C; Chen Z; Lu G
Cardiovasc Ther; 2012 Dec; 30(6):317-25. PubMed ID: 21884021
[TBL] [Abstract][Full Text] [Related]
5. Atorvastatin attenuates homocysteine-induced apoptosis in human umbilical vein endothelial cells via inhibiting NADPH oxidase-related oxidative stress-triggered p38MAPK signaling.
Bao XM; Wu CF; Lu GP
Acta Pharmacol Sin; 2009 Oct; 30(10):1392-8. PubMed ID: 19767766
[TBL] [Abstract][Full Text] [Related]
6. AMP-activated protein kinase functionally phosphorylates endothelial nitric oxide synthase Ser633.
Chen Z; Peng IC; Sun W; Su MI; Hsu PH; Fu Y; Zhu Y; DeFea K; Pan S; Tsai MD; Shyy JY
Circ Res; 2009 Feb; 104(4):496-505. PubMed ID: 19131647
[TBL] [Abstract][Full Text] [Related]
7. Activation of AMP-activated protein kinase protects against homocysteine-induced apoptosis of osteocytic MLO-Y4 cells by regulating the expressions of NADPH oxidase 1 (Nox1) and Nox2.
Takeno A; Kanazawa I; Tanaka K; Notsu M; Yokomoto M; Yamaguchi T; Sugimoto T
Bone; 2015 Aug; 77():135-41. PubMed ID: 25933943
[TBL] [Abstract][Full Text] [Related]
8. AMP-activated protein kinase activation by 5-aminoimidazole-4-carboxamide-1-beta-D-ribofuranoside (AICAR) inhibits palmitate-induced endothelial cell apoptosis through reactive oxygen species suppression.
Kim JE; Kim YW; Lee IK; Kim JY; Kang YJ; Park SY
J Pharmacol Sci; 2008 Mar; 106(3):394-403. PubMed ID: 18360094
[TBL] [Abstract][Full Text] [Related]
9. Overexpression of CYP2E1 induces HepG2 cells death by the AMP kinase activator 5'-aminoimidazole-4-carboxamide-1-beta-D-ribofuranoside (AICAR).
Zhuge J
Cell Biol Toxicol; 2009 Jun; 25(3):253-63. PubMed ID: 18473182
[TBL] [Abstract][Full Text] [Related]
10. Antiplatelet effect of AMP-activated protein kinase activator and its potentiation by the phosphodiesterase inhibitor dipyridamole.
Liu Y; Oh SJ; Chang KH; Kim YG; Lee MY
Biochem Pharmacol; 2013 Oct; 86(7):914-25. PubMed ID: 23876340
[TBL] [Abstract][Full Text] [Related]
11. Atorvastatin attenuates homocysteine-induced migration of smooth muscle cells through mevalonate pathway involving reactive oxygen species and p38 MAPK.
Bao XM; Zheng H
Clin Exp Pharmacol Physiol; 2015 Aug; 42(8):865-73. PubMed ID: 26041506
[TBL] [Abstract][Full Text] [Related]
12. Direct activation of AMP-activated protein kinase stimulates nitric-oxide synthesis in human aortic endothelial cells.
Morrow VA; Foufelle F; Connell JM; Petrie JR; Gould GW; Salt IP
J Biol Chem; 2003 Aug; 278(34):31629-39. PubMed ID: 12791703
[TBL] [Abstract][Full Text] [Related]
13. AMP-activated protein kinase promotes the differentiation of endothelial progenitor cells.
Li X; Han Y; Pang W; Li C; Xie X; Shyy JY; Zhu Y
Arterioscler Thromb Vasc Biol; 2008 Oct; 28(10):1789-95. PubMed ID: 18599796
[TBL] [Abstract][Full Text] [Related]
14. Nitric oxide inhibition of homocysteine-induced human endothelial cell apoptosis by down-regulation of p53-dependent Noxa expression through the formation of S-nitrosohomocysteine.
Lee SJ; Kim KM; Namkoong S; Kim CK; Kang YC; Lee H; Ha KS; Han JA; Chung HT; Kwon YG; Kim YM
J Biol Chem; 2005 Feb; 280(7):5781-8. PubMed ID: 15561702
[TBL] [Abstract][Full Text] [Related]
15. Activation of AMP-activated protein kinase by 5-aminoimidazole-4-carboxamide-1-beta-D-ribofuranoside in the muscle microcirculation increases nitric oxide synthesis and microvascular perfusion.
Bradley EA; Eringa EC; Stehouwer CD; Korstjens I; van Nieuw Amerongen GP; Musters R; Sipkema P; Clark MG; Rattigan S
Arterioscler Thromb Vasc Biol; 2010 Jun; 30(6):1137-42. PubMed ID: 20224051
[TBL] [Abstract][Full Text] [Related]
16. Endothelial AMPK activation induces mitochondrial biogenesis and stress adaptation via eNOS-dependent mTORC1 signaling.
Li C; Reif MM; Craige SM; Kant S; Keaney JF
Nitric Oxide; 2016 May; 55-56():45-53. PubMed ID: 26989010
[TBL] [Abstract][Full Text] [Related]
17. AMPK agonist AICAR ameliorates portal hypertension and liver cirrhosis via NO pathway in the BDL rat model.
Hu L; Su L; Dong Z; Wu Y; Lv Y; George J; Wang J
J Mol Med (Berl); 2019 Mar; 97(3):423-434. PubMed ID: 30721324
[TBL] [Abstract][Full Text] [Related]
18. Adiponectin suppression of high-glucose-induced reactive oxygen species in vascular endothelial cells: evidence for involvement of a cAMP signaling pathway.
Ouedraogo R; Wu X; Xu SQ; Fuchsel L; Motoshima H; Mahadev K; Hough K; Scalia R; Goldstein BJ
Diabetes; 2006 Jun; 55(6):1840-6. PubMed ID: 16731851
[TBL] [Abstract][Full Text] [Related]
19. A new constitutively active mutant of AMP-activated protein kinase inhibits anoxia-induced apoptosis of vascular endothelial cell.
Nagata D; Kiyosue A; Takahashi M; Satonaka H; Tanaka K; Sata M; Nagano T; Nagai R; Hirata Y
Hypertens Res; 2009 Feb; 32(2):133-9. PubMed ID: 19262472
[TBL] [Abstract][Full Text] [Related]
20. Adiponectin inhibits palmitate-induced apoptosis through suppression of reactive oxygen species in endothelial cells: involvement of cAMP/protein kinase A and AMP-activated protein kinase.
Kim JE; Song SE; Kim YW; Kim JY; Park SC; Park YK; Baek SH; Lee IK; Park SY
J Endocrinol; 2010 Oct; 207(1):35-44. PubMed ID: 20675307
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
